DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma ITMTX Vs IVMTX For CNS Relapse In High-Risk DLBCL Sep 27, 2023
DLBCL (Diffuse Large B Cell Lymphoma),FL (Follicular Lymphoma),Lymphoma Epcoritamab + R2 Regimen Improves Outcomes In Patients With High‑Risk Follicular Lymphoma Sep 26, 2023
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Radiation Omission in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results Sep 15, 2023
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma pola-R-miniCHP Shows Tolerability As A Potential Primary Treatment For Elderly DLBCL Pts Sep 13, 2023
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Glofitamab + Polatuzumab Show Durable Responses In R/R DLBCL With Manageable Safety Profile Sep 11, 2023
DLBCL (Diffuse Large B Cell Lymphoma) Results for Anti-CD19 Allogeneic Car T in R/R LBCL Sep 08, 2023
DLBCL (Diffuse Large B Cell Lymphoma) Bispecific Anti-CD20/19 CAR-T Zamtocabtagene Autoleucel Show Promising Results In R/R DLBCL Sep 06, 2023
DLBCL (Diffuse Large B Cell Lymphoma),FL (Follicular Lymphoma),Lymphoma,MCL (Mantle Cell Lymphoma),MZL (Marginal Zone Lymphoma) Liso-cel Proves Safe And Effective For R/R LBCL Patients Aug 30, 2023
